Cargando…
Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence
A major public health goal is to determine linkages between specific pollution sources and adverse health outcomes. This paper provides an integrative evaluation of the database examining effects of vehicular emissions, such as black carbon (BC), carbonaceous gasses, and ultrafine PM, on cardiovascu...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844969/ https://www.ncbi.nlm.nih.gov/pubmed/20376169 http://dx.doi.org/10.1007/s11869-009-0047-x |
_version_ | 1782179348500971520 |
---|---|
author | Grahame, Thomas J. Schlesinger, Richard B. |
author_facet | Grahame, Thomas J. Schlesinger, Richard B. |
author_sort | Grahame, Thomas J. |
collection | PubMed |
description | A major public health goal is to determine linkages between specific pollution sources and adverse health outcomes. This paper provides an integrative evaluation of the database examining effects of vehicular emissions, such as black carbon (BC), carbonaceous gasses, and ultrafine PM, on cardiovascular (CV) morbidity and mortality. Less than a decade ago, few epidemiological studies had examined effects of traffic emissions specifically on these health endpoints. In 2002, the first of many studies emerged finding significantly higher risks of CV morbidity and mortality for people living in close proximity to major roadways, vs. those living further away. Abundant epidemiological studies now link exposure to vehicular emissions, characterized in many different ways, with CV health endpoints such as cardiopulmonary and ischemic heart disease and circulatory-disease-associated mortality; incidence of coronary artery disease; acute myocardial infarction; survival after heart failure; emergency CV hospital admissions; and markers of atherosclerosis. We identify numerous in vitro, in vivo, and human panel studies elucidating mechanisms which could explain many of these cardiovascular morbidity and mortality associations. These include: oxidative stress, inflammation, lipoperoxidation and atherosclerosis, change in heart rate variability (HRV), arrhythmias, ST-segment depression, and changes in vascular function (such as brachial arterial caliber and blood pressure). Panel studies with accurate exposure information, examining effects of ambient components of vehicular emissions on susceptible human subjects, appear to confirm these mechanisms. Together, this body of evidence supports biological mechanisms which can explain the various CV epidemiological findings. Based upon these studies, the research base suggests that vehicular emissions are a major environmental cause of cardiovascular mortality and morbidity in the United States. As a means to reduce the public health consequences of such emissions, it may be desirable to promulgate a black carbon (BC) PM(2.5) standard under the National Ambient Air Quality Standards, which would apply to both on and off-road diesels. Two specific critical research needs are identified. One is to continue research on health effects of vehicular emissions, gaseous as well as particulate. The second is to utilize identical or nearly identical research designs in studies using accurate exposure metrics to determine whether other major PM pollutant sources and types may also underlie the specific health effects found in this evaluation for vehicular emissions. |
format | Text |
id | pubmed-2844969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-28449692010-04-05 Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence Grahame, Thomas J. Schlesinger, Richard B. Air Qual Atmos Health Article A major public health goal is to determine linkages between specific pollution sources and adverse health outcomes. This paper provides an integrative evaluation of the database examining effects of vehicular emissions, such as black carbon (BC), carbonaceous gasses, and ultrafine PM, on cardiovascular (CV) morbidity and mortality. Less than a decade ago, few epidemiological studies had examined effects of traffic emissions specifically on these health endpoints. In 2002, the first of many studies emerged finding significantly higher risks of CV morbidity and mortality for people living in close proximity to major roadways, vs. those living further away. Abundant epidemiological studies now link exposure to vehicular emissions, characterized in many different ways, with CV health endpoints such as cardiopulmonary and ischemic heart disease and circulatory-disease-associated mortality; incidence of coronary artery disease; acute myocardial infarction; survival after heart failure; emergency CV hospital admissions; and markers of atherosclerosis. We identify numerous in vitro, in vivo, and human panel studies elucidating mechanisms which could explain many of these cardiovascular morbidity and mortality associations. These include: oxidative stress, inflammation, lipoperoxidation and atherosclerosis, change in heart rate variability (HRV), arrhythmias, ST-segment depression, and changes in vascular function (such as brachial arterial caliber and blood pressure). Panel studies with accurate exposure information, examining effects of ambient components of vehicular emissions on susceptible human subjects, appear to confirm these mechanisms. Together, this body of evidence supports biological mechanisms which can explain the various CV epidemiological findings. Based upon these studies, the research base suggests that vehicular emissions are a major environmental cause of cardiovascular mortality and morbidity in the United States. As a means to reduce the public health consequences of such emissions, it may be desirable to promulgate a black carbon (BC) PM(2.5) standard under the National Ambient Air Quality Standards, which would apply to both on and off-road diesels. Two specific critical research needs are identified. One is to continue research on health effects of vehicular emissions, gaseous as well as particulate. The second is to utilize identical or nearly identical research designs in studies using accurate exposure metrics to determine whether other major PM pollutant sources and types may also underlie the specific health effects found in this evaluation for vehicular emissions. Springer Netherlands 2009-06-30 2010 /pmc/articles/PMC2844969/ /pubmed/20376169 http://dx.doi.org/10.1007/s11869-009-0047-x Text en © Springer Science+Business Media B.V. 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Grahame, Thomas J. Schlesinger, Richard B. Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title | Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title_full | Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title_fullStr | Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title_full_unstemmed | Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title_short | Cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
title_sort | cardiovascular health and particulate vehicular emissions: a critical evaluation of the evidence |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844969/ https://www.ncbi.nlm.nih.gov/pubmed/20376169 http://dx.doi.org/10.1007/s11869-009-0047-x |
work_keys_str_mv | AT grahamethomasj cardiovascularhealthandparticulatevehicularemissionsacriticalevaluationoftheevidence AT schlesingerrichardb cardiovascularhealthandparticulatevehicularemissionsacriticalevaluationoftheevidence |